Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
417,000
+9,500 (2.33%)
Last updated: Aug 11, 2026, 10:58 AM KST

Hanmi Pharm. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
172,439169,554121,315146,23182,79267,025
Depreciation & Amortization
99,02998,80997,33198,45496,84289,086
Loss (Gain) From Sale of Assets
-16.26-101.2-27.74-1,769-451.651,062
Asset Writedown & Restructuring Costs
3,0883,0132,4889,1533,794535.2
Loss (Gain) From Sale of Investments
-4,329-4,76287.92-2,630-47.09-
Loss (Gain) on Equity Investments
18.917.459.2-1,2588,5374.02
Provision & Write-off of Bad Debts
3,3343,346-593.891,277723.065,118
Other Operating Activities
58,21053,27463,14024,47643,76692,609
Change in Accounts Receivable
-74,088-87,255-61,052-3,21737,286-76,613
Change in Inventory
-73,906-37,0351,928-16,903-14,36518,916
Change in Accounts Payable
16,62212,458-10,4385,574-2,7369,794
Change in Other Net Operating Assets
4,966-38,238-20,701-42,852-93,870-5,613
Operating Cash Flow
205,368173,072193,487216,538162,269201,923
Operating Cash Flow Growth
41.53%-10.55%-10.64%33.44%-19.64%33.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-51,451-43,025-39,261-27,352-30,378-19,949
Sale of Property, Plant & Equipment
322.35462.7250.862,6001,39786.37
Sale (Purchase) of Intangibles
-29,967-32,997-22,768-16,156-20,273-14,199
Investment in Securities
38,113-53,626103,827-138,865-118,609-6,953
Other Investing Activities
-4,569-3,974-3,650-3,699-13,545-2,375
Investing Cash Flow
-82,402-159,45524,851-183,472-181,408-43,389

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-142,400431,830134,650230,000102,700
Long-Term Debt Issued
-38,00049,000-7,00030,000
Total Debt Issued
177,900180,400480,830134,650237,000132,700
Short-Term Debt Repaid
--193,500-472,330-202,650-116,800-198,800
Long-Term Debt Repaid
--53,234-86,431-37,720-147,240-36,476
Total Debt Repaid
-236,826-246,734-558,761-240,370-264,040-235,276
Net Debt Issued (Repaid)
-58,926-66,334-77,931-105,720-27,040-102,576
Issuance of Common Stock
00----
Repurchase of Common Stock
---3,280-3,071-3,834-4,874
Dividends Paid
-14,358-30,855-12,555-17,996-5,992-5,881
Other Financing Activities
-0---0--
Financing Cash Flow
-73,285-97,190-93,767-126,787-36,867-113,331

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
6,361-431.3212,7271,373-5,89017,864
Net Cash Flow
56,043-84,004137,297-92,348-61,89663,067

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
153,918130,048154,226189,186131,890181,974
Free Cash Flow Growth
38.45%-15.68%-18.48%43.44%-27.52%65.85%
Free Cash Flow Margin
9.93%8.40%10.31%12.69%9.90%15.12%
Free Cash Flow Per Share
12128.3710248.7712162.1314906.6710382.3714307.73
Levered Free Cash Flow
35,9402,284132,235156,408193,044159,618
Unlevered Free Cash Flow
45,49712,901147,468174,226207,199169,979

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
14,35517,06024,74727,84619,49818,315
Cash Income Tax Paid
38,82946,29022,12031,43229,6326,599
Change in Working Capital
-126,405-150,069-90,263-57,397-73,686-53,516